lipoprotein lipase (LPL): enzyme that stimulates lipolysis, breaks of TG into FA and glycerol, they can then enter cells
VLDL: synthesized in liver, transport endogenous fats
VLDLs made in liver ER with ApoB-100
Fructose: stays in the liver, more lipogenic than glucose
LPL recognizes Apo-CII on VLDLs to take up TAGS into skeletal muscle and adipose tissue
Insulin: promotes uptake of TAGs into adipose tissue bc this is primary storage site
Skeletal muscle and heart have access to FAs for fuel during fasted state
steroid hormones are synthesized from cholesterol: sex hormones, cortisol, aldosterone
bile acids are made from CE: makes it emulsifier for lipids during digestion
Isoprenoids: made from CE precursors, makes up vitamin D
CE synthesis: 3 acetyl-CoA combine to form HMG-CoA, then HMG-CoA turns to mevalonate by HMG-CoA reductase
Statins: taget HMG-CoA reductase, blocks the synthesis of mevalonate
HMGCR: catalytic domain is in cytosol, sterol-sensing domain is in the ER lumen. sterol-sensing responds to high CE, HMGCR will leave membrane and be degraded
Mevalonate: goes into pathway to form vitamin D, steroid hormones, and bile acids
HMGCR: active in dephosphorylated state, inactive when phosphorylated
HMGCR: high CE: translocate out of ER membrane: low CE: transcription factor promotes its gene expression
Dyslipidemia: abnormal blood lipids, low HDL, high LDL, high total-C, high TG. want high HDL and low LDL
Foam cell: LDL combines with macrophage, HDL is protective bc it removes CE from the macrophage
small LDL particle size is an increased risk factor for CVD